Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk.
Saved in:
| Title: | Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk. |
|---|---|
| Authors: | Heinrich M; Research Group 'Pharmacognosy and Phytotherapy', UCL School of Pharmacy, University of London, London, United Kingdom., Scotti F; Research Group 'Pharmacognosy and Phytotherapy', UCL School of Pharmacy, University of London, London, United Kingdom., Andrade-Cetto A; Laboratorio de Etnofarmacología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico., Berger-Gonzalez M; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala., Echeverría J; Departamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile., Friso F; Departmento de Investigación, Centro de Rehabilitación de Toxicómanos y de Investigación de Medicinas Tradicionales-Takiwasi, Tarapoto, Peru., Garcia-Cardona F; Instituto de Investigación de Recursos Biológicos, Alexander von Humboldt, Sede Venado del Oro, Bogotá, Colombia., Hesketh A; Indigena Biodiversity Limited, Gerrards Cross, United Kingdom., Hitziger M; Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland., Maake C; Institute of Anatomy, University of Zurich, Zurich, Switzerland., Politi M; Departmento de Investigación, Centro de Rehabilitación de Toxicómanos y de Investigación de Medicinas Tradicionales-Takiwasi, Tarapoto, Peru.; Department of Pharmacy, University of Chieti-Pescara, Chieti Scalo, Italy., Spadafora C; Centro de Biología Celular y Molecular de Enfermedades (CBCMe), Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama City, Panamá., Spadafora R; Asociación Nacional de Conservación de la Naturaleza (National Association for the Conservation of Nature), Cd. de Panama City, Panamá. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2020 Jun 08; Vol. 11, pp. 765. Date of Electronic Publication: 2020 Jun 08 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32581783 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Heinrich+M%22">Heinrich M</searchLink>; Research Group 'Pharmacognosy and Phytotherapy', UCL School of Pharmacy, University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Scotti+F%22">Scotti F</searchLink>; Research Group 'Pharmacognosy and Phytotherapy', UCL School of Pharmacy, University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Andrade-Cetto+A%22">Andrade-Cetto A</searchLink>; Laboratorio de Etnofarmacología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico.<br /><searchLink fieldCode="AU" term="%22Berger-Gonzalez+M%22">Berger-Gonzalez M</searchLink>; Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala.<br /><searchLink fieldCode="AU" term="%22Echeverría+J%22">Echeverría J</searchLink>; Departamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Friso+F%22">Friso F</searchLink>; Departmento de Investigación, Centro de Rehabilitación de Toxicómanos y de Investigación de Medicinas Tradicionales-Takiwasi, Tarapoto, Peru.<br /><searchLink fieldCode="AU" term="%22Garcia-Cardona+F%22">Garcia-Cardona F</searchLink>; Instituto de Investigación de Recursos Biológicos, Alexander von Humboldt, Sede Venado del Oro, Bogotá, Colombia.<br /><searchLink fieldCode="AU" term="%22Hesketh+A%22">Hesketh A</searchLink>; Indigena Biodiversity Limited, Gerrards Cross, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hitziger+M%22">Hitziger M</searchLink>; Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Maake+C%22">Maake C</searchLink>; Institute of Anatomy, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Politi+M%22">Politi M</searchLink>; Departmento de Investigación, Centro de Rehabilitación de Toxicómanos y de Investigación de Medicinas Tradicionales-Takiwasi, Tarapoto, Peru.; Department of Pharmacy, University of Chieti-Pescara, Chieti Scalo, Italy.<br /><searchLink fieldCode="AU" term="%22Spadafora+C%22">Spadafora C</searchLink>; Centro de Biología Celular y Molecular de Enfermedades (CBCMe), Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama City, Panamá.<br /><searchLink fieldCode="AU" term="%22Spadafora+R%22">Spadafora R</searchLink>; Asociación Nacional de Conservación de la Naturaleza (National Association for the Conservation of Nature), Cd. de Panama City, Panamá. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2020 Jun 08; Vol. 11, pp. 765. <i>Date of Electronic Publication: </i>2020 Jun 08 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32581783 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2020.00765 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 765 Titles: – TitleFull: Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Heinrich M – PersonEntity: Name: NameFull: Scotti F – PersonEntity: Name: NameFull: Andrade-Cetto A – PersonEntity: Name: NameFull: Berger-Gonzalez M – PersonEntity: Name: NameFull: Echeverría J – PersonEntity: Name: NameFull: Friso F – PersonEntity: Name: NameFull: Garcia-Cardona F – PersonEntity: Name: NameFull: Hesketh A – PersonEntity: Name: NameFull: Hitziger M – PersonEntity: Name: NameFull: Maake C – PersonEntity: Name: NameFull: Politi M – PersonEntity: Name: NameFull: Spadafora C – PersonEntity: Name: NameFull: Spadafora R IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 06 Text: 2020 Jun 08 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |